HSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury

Experimental Neurology

Volumn 183, Issue 1, 2003, Pages 47-55

  Harvey, B K ^a   Chang, C F ^b,c   Chiang, Y H ^c   Bowers, W J ^a   Morales, M ^b   Hoffer, B J ^b   Wang, Y ^b   Federoff, H J ^a,d  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Amplicon; GDNF; Gene therapy; Herpes simplex; Ischemia; Stroke

Indexed keywords

CASPASE 3; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROPROTECTIVE AGENT; RECOMBINANT GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

AMPLICON; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYKINESIA; BRAIN CORTEX; BRAIN INJURY; BRAIN ISCHEMIA; CONTROLLED STUDY; EMBRYO; HERPES SIMPLEX VIRUS; IMMUNOHISTOCHEMISTRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STROKE;

EID: 0043192384     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00080-3     Document Type: Article

References (31)

1. Abe K., Setoguchi Y., Hayashi T., Itoyama Y. In vivo adenovirus-mediated gene transfer and the expression in ischemic and reperfused rat brain. Brain Res. 763:1997;191-201.
2. Antonawich F.J., Federoff H.J., Davis J.N. BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia. Exp. Neurol. 156:1999;130-137.
3. Borlongan C.V., Hida H., Nishino H. Early assessment of motor dysfunctions aids in successful occlusion of the middle cerebral artery. Neuroreport. 9:1998;3615-3621.
4. Bowers W.J., Howard D.F., Brooks A.I., Halterman M.W., Federoff H.J. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers. Gene Ther. 8:2001;111-120.
5. Bowers W.J., Howard D.F., Federoff H.J. Discordance between expression and genome transfer titering of HSV amplicon vectors: recommendation for standardized enumeration. Mol. Ther. 1:2000;294-299.
6. Cartmell T., Southgate T., Rees G.S., Castro M.G., Lowenstein P.R., Luheshi G.N. Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. J. Neurosci. 19:1999;1517-1523.
7. Chen S.T., Hsu C.Y., Hogan E.L., Maricq H., Balentine J.D. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 17:1986;738-743.
8. Chiang Y.H., Lin S.Z., Borlongan C.V., Hoffer B.J., Morales M., Wang Y. Transplantation of fetal kidney tissue reduces cerebral infarction induced by middle cerebral artery ligation. J. Cereb. Blood Flow Metab. 19:1999;1329-1335.
9. Driesse M.J., Esandi M.C., Kros J.M., Avezaat C.J., Vecht C., Zurcher C., van der Velde I., Valerio D., Bout A., Sillevis Smitt P.A. Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity. Gene Ther. 7:2000;1401-1409.
10. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25:2000;1439-1451.
11. Graham S.H., Chen J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21:2001;99-109.
12. Hyslop P.A., Zhang Z., Pearson D.V., Phebus L.A. Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res. 671:1995;181-186.
13. Ikeda T., Ikenoue T., Xia X.Y., Xia Y.X. Important role of 72-kd heat shock protein expression in the endothelial cell in acquisition of hypoxic-ischemic tolerance in the immature rat. Am. J. Obstet. Gynecol. 182:2000;380-386.
14. Jia W.W., Wang Y., Qiang D., Tufaro F., Remington R., Cynader M. A bcl-2 expressing viral vector protects cortical neurons from excitotoxicity even when administered several hours after the toxic insult. Brain Res. Mol. Brain Res. 42:1996;350-353.
15. Kitagawa H., Abe K., Hayashi T., Mitsumoto Y., Koga N., Itoyama Y. Ameliorative effect of glial cell line-derived neurotrophic factor on brain edema formation after permanent middle cerebral artery occlusion in rats. Neurol. Res. 20:1998;333-336.
16. Kitagawa H., Sasaki C., Sakai K., Mori A., Mitsumoto Y., Mori T., Fukuchi Y., Setoguchi Y., Abe K. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 19:1999;1336-1344.
17. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:1987;83-90.
18. Lawrence M.S., McLaughlin J.R., Sun G.H., Ho D.Y., McIntosh L., Kunis D.M., Sapolsky R.M., Steinberg G.K. Herpes simplex viral vectors expressing Bcl-2 are neuroprotective when delivered after a stroke. J. Cereb. Blood Flow Metab. 17:1997;740-744.
19. Lawrence M.S., Sun G.H., Kunis D.M., Saydam T.C., Dash R., Ho D.Y., Sapolsky R.M., Steinberg G.K. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J. Cereb. Blood Flow Metab. 16:1996;181-185.
20. Lin S.Z., Hoffer B.J., Kaplan P., Wang Y. Osteogenic protein-1 protects against cerebral infarction induced by MCA ligation in adult rats. Stroke. 30:1999;126-133.
21. Linnik M.D., Zahos P., Geschwind M.S., Federoff H.J. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke. 26:1995;1670-1675.
22. Lu B., Federoff H.J. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum. Gene Ther. 6:1995;419-428.
23. Miyazaki H., Okuma Y., Fujii Y., Nagashima K., Nomura Y. Glial cell line-derived neurotrophic factor protects against delayed neuronal death after transient forebrain ischemia in rats. Neuroscience. 89:1999;643-647.
24. Okragly A.J., Haak-Frendscho M. An acid-treatment method for the enhanced detection of GDNF in biological samples. Exp. Neurol. 145:1997;592-596.
25. Reier P.J., Houle J.D. The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv. Neurol. 47:1988;87-138.
26. Stavropoulos T.A., Strathdee C.A. An enhanced packaging system for helper-dependent herpes simplex virus vectors. J. Virol. 72:1998;7137-7143.
27. Tsai T.H., Chen S.L., Chiang Y.H., Lin S.Z., Ma H.I., Kuo S.W., Tsao Y.P. Recombinant adeno-associated virus vector expressing glial cell line-derived neurotrophic factor reduces ischemia-induced damage. Exp. Neurol. 166:2000;266-275.
28. Wang Y., Hayashi T., Chang C.F., Chiang Y.H., Tsao L.I., Su T.P., Borlongan C., Lin S.Z. Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke. 32:2001;775-782.
29. Wang Y., Lin S.Z., Chiou A.L., Williams L.R., Hoffer B.J. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J. Neurosci. 17:1997;4341-4348.
30. Yagi T., Jikihara I., Fukumura M., Watabe K., Ohashi T., Eto Y., Hara M., Maeda M. Rescue of ischemic brain injury by adenoviral gene transfer of glial cell line-derived neurotrophic factor after transient global ischemia in gerbils. Brain Res. 885:2000;273-282.
31. Yenari M.A., Fink S.L., Sun G.H., Chang L.K., Patel M.K., Kunis D.M., Onley D., Ho D.Y., Sapolsky R.M., Steinberg G.K. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann. Neurol. 44:1998;584-591.